Wednesday, 23 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14471
Articles
Company
Drug
Hengrui Medicine’s Pyrotinib Filing Accepted for Review by NMPA
February 3, 2025
Company
Deals
China Resources Partners with Fosun Pharma to Expand Global Healthcare Footprint
February 3, 2025
Company
Drug
NMPA Approves JW Therapeutics’ Carteyva for Recurrent Follicular Lymphoma
February 3, 2025
Company
Drug
Innovent’s Cyramza Gains NMPA Approval for Hepatocellular Carcinoma
February 3, 2025
Company
Drug
Sciwind Biosciences Initiates US Phase I Study for GLP-1 Agonist XW014
February 3, 2025
Company
Deals
Fujian Cosunter to Acquire UDCA Capsules Technology from Ruitailai
February 3, 2025
Company
Drug
Fujian Cosunter Doses First Patient in Phase I Study of COVID-19 Drug GST-HG171
February 3, 2025
Company
Drug
Salubris Pharmaceuticals’ First-in-Class Anti-Tumor Drug SAL008 Accepted by NMPA
February 3, 2025
Company
Drug
Roche’s Subcutaneous Herceptin Approved in China for HER2-Positive Breast Cancer
February 3, 2025
Policy / Regulatory
CDE Releases 63rd Batch of Chemical Generic Reference Preparations
February 3, 2025
Policy / Regulatory
Jiangsu Launches Sunshine Procurement Platform for Drugs and Medical Consumables
February 3, 2025
Company
Drug
Merck’s Keytruda Gains 9th Indication Approval in China for Hepatocellular Carcinoma
February 3, 2025
1
2
…
1,124
1,125
1,126
1,127
1,128
…
1,205
1,206
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?